Dr. Dereck Mush, MD, MBA

CEO @Teknon / Smart people and capable businesses keep losing to louder ones. I fix that. → Helped 300+ leaders Package, Position, & Sell their Expertise | Scaled by AI Systems | HealthTech 🧬

Nov 9, 2026

Cordio's Voice AI Flags Heart Failure Events 24 Days Early

PLUS: CMS Writes Software Payment and Remote Monitoring Guardrails Into the 2027 Rules

Dr. Dereck Mush, MD, MBA

Nov 6, 2026

Luma Health Puts AI Agents on Procedure Prep With 95% Patient Response

PLUS: Ellipsis Health Buys Kouper to Wire AI Care Calls Into the EHR

Dr. Dereck Mush, MD, MBA

Nov 5, 2026

CVS Health Plans to Split Into Two Public Companies

PLUS: GE HealthCare Leads Up to $160M Series B in AI-Guided Cath Lab Startup Laza Medical

Dr. Dereck Mush, MD, MBA

Nov 4, 2026

Mayo Clinic Platform Puts AI Decision Support Inside the EHR

PLUS: LeanTaaS Buys LookDeep to Bring Computer Vision Into Hospital Operations

Dr. Dereck Mush, MD, MBA

Nov 3, 2026

athenahealth Lets Patients Bring Their Records Into Anthropic's Claude

PLUS: Ceribell Launches AI EEG Delirium Monitoring on Its Seizure Platform

Dr. Dereck Mush, MD, MBA

Nov 2, 2026

CT-Guided PCI Planning Matches IVUS in the 1,105-Patient P4 Trial at TCT 2026

PLUS: The FDA Approves VOCERYQ, the First Plasmid DNA-Based Immunotherapy in the U.S.

Dr. Dereck Mush, MD, MBA

Oct 30, 2026

OpenEvidence Moves Inside NYU Langone's Epic Chart

PLUS: StimCardio raises $30M to take a wrist-worn AF therapy into a pivotal trial

Dr. Dereck Mush, MD, MBA

Oct 29, 2026

Leeds ED Cuts Documentation Time 61% With TORTUS Ambient Voice

PLUS: Senseonics Freedom Enters Humans. ClarityCare Raises $16.5M for Prior Auth.

Dr. Dereck Mush, MD, MBA

Oct 28, 2026

Coherence Neuro Raises $45M Co-Led by Founders Fund and OpenAI to Treat Brain Cancer with Bioelectronic AI

PLUS: Multiply Labs Lands $75M Series B Led by Patrick Soon-Shiong to Automate Cell and Gene Therapy Manufacturing

Dr. Dereck Mush, MD, MBA

Oct 27, 2026

Stryker Commits $400M to CMR Surgical in Landmark US Multi-Port Robotics Pact

PLUS: Scarlet Secures $50M Series B to Fast-Track AI Medical Device Certification

Dr. Dereck Mush, MD, MBA

Oct 26, 2026

UVM Wins $38M ARPA-H Contract to Build Real-Time AI Digital Twins for ICU Sepsis and Trauma

PLUS: Eko Health Clears FDA 510(k) for CORE 300 AI Stethoscope to Scale Pediatric and Adult Cardiac Triage

Dr. Dereck Mush, MD, MBA

Oct 23, 2026

Eko Health Launches CORE 300 AI Stethoscope Following FDA Clearance

PLUS: BioStack Launches 100M+ Record Multimodal Network with $9.5M Seed

Dr. Dereck Mush, MD, MBA

Oct 22, 2026

Phantom Neuro Implants Minimally Invasive Sub-Dermal Neural Interface in First Human CYBORG Trial Participants

PLUS: XRlabs Closes $8.4M Seed Led by Playground Global to Deploy NVIDIA Jetson Thor Physical AI in Operating Rooms

Dr. Dereck Mush, MD, MBA

Oct 21, 2026

AI Replaces Biopsy Calipers: FDA Clears TumorSight Risk for Breast Cancer

PLUS: Doximity embeds UpToDate for 2M doctors and Khosla backs Even $50M

Dr. Dereck Mush, MD, MBA

Oct 20, 2026

EchoNext Earns TIME Recognition for AI Heart Screening

PLUS: Oracle and AstraZeneca Team Up on Clinical Research

Dr. Dereck Mush, MD, MBA

Oct 19, 2026

SimBioSys Announces FDA Clearance for Breast Cancer Recurrence-Risk Tool

PLUS: Scarlet Raises $50M to Expand AI Medical Device Certification

Dr. Dereck Mush, MD, MBA

Oct 17, 2026

CMS and FDA Advance RAPID Coverage Pathway to Compress Medicare Device Reimbursement to 60 Days

PLUS: AstraZeneca and insitro Strike AI Drug-Discovery Deal With $40M Upfront

Dr. Dereck Mush, MD, MBA

Oct 16, 2026

HHS and FDA Leadership Break with CHAI, Warning Against Private 'Regulatory Cartel' in Healthcare AI

PLUS: Patient-Directed AI Record Access: What Providers Need to Get Right

Dr. Dereck Mush, MD, MBA

Oct 15, 2026

Medical AI Trials Are Leaving Crucial Details Out

PLUS: I’m Speaking in Munich About Why Good MedTech Fails

Dr. Dereck Mush, MD, MBA

Oct 14, 2026

Agilent Buys Proscia for $270M, Suki Raises $90M, and J&J OTTAVA Wins FDA nod

PLUS: Consolidating the digital slide: why enterprise instrument makers are swallowing pathology AI

Dr. Dereck Mush, MD, MBA

Oct 13, 2026

Google's $180 Hardware Bet, Abridge's Texas Expansion, and Robotic Brain Implants

PLUS: Inside Google's 7-day battery architecture, enterprise ambient AI governance, and graphene BCI robotics

Dr. Dereck Mush, MD, MBA

Oct 12, 2026

Pharvaris Phase 3 Lancet Trial Proves Oral Deucrictibant Stops HAE Attacks in 1.28 Hours.

PLUS: AbbVie wins double FDA Breakthrough status for c-Met Top1i ADC in solid tumors.

Dr. Dereck Mush, MD, MBA

Oct 10, 2026

FDA Approves Teva's Weltruza as First Once-Monthly Olanzapine Without 3-Hour Monitoring.

PLUS: argenx's CD122 inhibitor proves villus healing in Phase 2 celiac trial.

Dr. Dereck Mush, MD, MBA

Oct 9, 2026

FDA Approves Genentech's Tecentriq for Stage III dMMR Colon Cancer.

PLUS: MRI2CT's AI generates 3D bone CTs from routine spine MRIs.

Dr. Dereck Mush, MD, MBA

Oct 8, 2026

FDA Approves Chemotherapy-Free Maintenance in Frontline HER2-Positive Breast Cancer.

PLUS: How Novartis took oral BTK inhibition into physical friction hives.

Dr. Dereck Mush, MD, MBA